Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
388.44+4.92 (+1.28%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 383.52 |
| Open | 387.19 |
| Bid | 386.72 x 1200 |
| Ask | 392.88 x 900 |
| Day's Range | 381.65 - 390.47 |
| 52 Week Range | 223.25 - 468.55 |
| Volume | 2,831,488 |
| Avg. Volume | 1,724,455 |
| Market Cap | 58.482B |
| Beta (5Y Monthly) | 0.44 |
| PE Ratio (TTM) | 20.14 |
| EPS (TTM) | 19.29 |
| Earnings Date | Jul 20, 2021 - Jul 26, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 405.41 |
- Zacks
Biogen (BIIB) Initiates Late-Stage Study on Lupus Candidate
Biogen (BIIB) is developing its monoclonal antibody candidate, BIIB059, as a potential treatment for active systemic lupus erythematosus.
- Investor's Business Daily
Six Big Stocks Post Exciting Fast Gains In This 'Dull' Market
Investors know it's risky to bet against a dull market. But some S&P 500 stocks are starting to give investors a real thrill on the upside.
- Investor's Business Daily
Dow Jones Dives As Stocks Tumble In Quadruple Witching Trade; Adobe Leaps On Earnings; Lennar, Biogen Upgraded
Earnings news boosted Adobe, Goldman Sachs broke technical support on the Dow Jones, and stocks fell into a quadruple witching session.
© 2021 Verizon Media. All rights reserved.
